Celldex Therapeutics
CLDX
#4691
Rank
C$2.74 B
Marketcap
C$41.30
Share price
6.44%
Change (1 day)
10.41%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -C$0.37 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are C$2.6 Million. In 2024 the company made an earning of -C$0.28 Billion a decrease over its 2023 earnings that were of -C$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.37 Billion32.29%
2024 -C$0.28 Billion37.34%
2023 -C$0.2 Billion32.63%
2022 -C$0.15 Billion54.88%
2021 -C$96.48 Million39.49%
2020 -C$69.17 Million-9.08%
2019 -C$76.08 Million-28.64%
2018 -C$0.11 Billion-30.11%
2017 -C$0.16 Billion-17.75%
2016 -C$0.19 Billion4.5%
2015 -C$0.18 Billion4.09%
2014 -C$0.18 Billion51.57%
2013 -C$0.12 Billion40.1%
2012 -C$80.3 Million
2010 -C$1.74 Million-96.59%
2009 -C$51.07 Million
2006 -C$31.21 Million
2004 -C$18.96 Million15.75%
2003 -C$16.38 Million-18.69%
2002 -C$20.14 Million-41.22%
2001 -C$34.26 Million59%
2000 -C$21.55 Million27.65%
1999 -C$16.88 Million53.12%
1998 -C$11.03 Million2.6%
1997 -C$10.75 Million-33.62%
1996 -C$16.19 Million-1.69%
1995 -C$16.47 Million22.92%
1994 -C$13.4 Million-0%
1993 -C$13.4 Million
1991 -C$8.24 Million90.32%
1990 -C$4.33 Million10.71%
1989 -C$3.91 Million833.33%
1988 -C$0.42 Million-400%
1987 C$0.13 M-125%
1986 -C$0.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-C$1.11 Billion 208.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$28.82 M-108.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.23 B-164.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.50 B-3,317.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.53 B-4,725.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$13.00 B-3,738.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-C$3.92 Million-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA